EVICORE SAVE
DEAD

Serial Number

97923385

Owner

EVICORE HEALTHCARE MSI, LLC

Attorney

Alexandra MacKay

Filing Date

May 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

EVICORE SAVE Trademark

Serial Number: 97923385

EVICORE SAVE is a trademark filed by EVICORE HEALTHCARE MSI, LLC on May 5, 2023. The trademark is classified under Class 36 (Insurance & Financial), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

EVICORE HEALTHCARE MSI, LLC (31 trademarks)

400 BUCKWALTER PLACE BLVD.
BLUFFTON, SC 29910

Entity Type: 16

Trademark Details

Filing Date

May 5, 2023

Registration Date

Not Registered

Published for Opposition

August 13, 2024

Goods & Services

Pharmacy benefit management services; medical benefit management services; medical and pharmacy benefit management services, namely, tracking, monitoring, assessing and analyzing information and statistics regarding patient prescription drug use, medical care, and healthcare habits, to identify potential cost savings and clinical benefits; claims administration services in the field of health insurance; medical insurance case and utilization review and insurance claims adjustment services for healthcare purchasers, payers, providers, and beneficiaries of health plans; administration of managed health care plans; insurance administration in the field of health care; insurance services, namely, administration of healthcare benefit insurance plans

Cost management for the health and prescription drug plans of others in the field of pharmaceuticals, clinical care and health care treatment; business services in the nature of pharmaceutical cost management, namely, prescription drug formulary cost management services; consulting services in the cost management of healthcare and pharmacy services; Pharmaceutical cost management services and drug utilization review services; medical cost management; managed care services, namely, utilization review and pre-certification services; evidence-based health care cost management services and healthcare utilization and review services; patient relationship management services and pharmaceutical cost management; medical and pharmaceutical cost management services in the fields of medical oncology, radiation therapy, genetic laboratory services, diagnostic radiology, inpatient admissions, cancer surgery, and healthcare services in the field of oncology; Drug utilization review services and drug formulary cost and business management services; strategic business analysis and business advice regarding pharmacy benefit management, pharmaceutical end-user behavior, healthcare use behavior; market study and analysis of market studies in the fields of healthcare, healthcare benefits, and pharmacy benefits effecting health behavior change and choice at the patient level, providing business intelligence services in the field of pharmacy benefit management; Cost management and business management of the health care benefit plans of others in the field of oncology, namely, management related to chemotherapy benefits, infusion treatment benefits, injection treatment benefits and other treatment benefits in the field of oncology; organization and coordination of health care services, namely, utilization management, prior authorization, claims adjudication, and clinical decision support for medical oncology services, radiation therapy, diagnostic radiology services, hospital admissions, and surgery

Advisory services and consultancy in the field of healthcare; healthcare services, namely, disease management programs; consulting services in the field of health

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
May 12, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
May 12, 2025 ABN6
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 8, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Aug 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 19, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 19, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 19, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 8, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 8, 2024 CNRT
ASSIGNED TO EXAMINER
Jan 30, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 5, 2023 NWOS
NEW APPLICATION ENTERED
May 9, 2023 NWAP